Dr. Beth Karlan is a leader in the field of research on early detection of ovarian cancer. She has received research grants from the Department of Defense, National Institutes of Health and the American Cancer Institute. Her research interests include the genetic definition and phenotypic determinants of human ovarian carcinomas, molecular biomarker discovery and inherited cancer susceptibility. This year, she is our winner of the Rosalind Franklin Excellence in Ovarian Cancer Research Award due to her commitment to innovative ovarian cancer research.
Related Topics
KIRO-TV 7 Seattle (CBS) Spotlights 2025 OCRA Rivkin Family SummeRun and Community
The 2025 OCRA Rivkin Family SummeRun brought together more than 900 participants in Seattle to raise critical funds for ovarian cancer research. KIRO-TV 7 Seattle (CBS) covered the event in … Continued
KZJO-TV Fox 13 Seattle’s Live Broadcast Gives Viewers a First-Hand Look at OCRA Rivkin Family SummeRun
KZJO-TV Fox 13 Seattle broadcast live all morning from the Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun at Seward Park on July 13, 2025, giving viewers a first-hand look … Continued
OCRA Rivkin Family SummeRun Raises $320K+ for Ovarian Cancer Research
More than 900 participants gathered at Seattle’s Seward Park on July 13, 2025, for the Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun. Now in its 32nd year, the beloved … Continued